podoplanin Antibodies

Santa Cruz Biotechnology features a diverse variety of podoplanin monoclonal antibodies for research applications. Podoplanin monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Podoplanin is a glycoprotein that plays a significant role in lymphatic development, cell migration, and tumor progression. Expression of podoplanin occurs primarily in lymphatic endothelial cells and has been linked to various pathological conditions, including cancer metastasis and inflammation. Understanding podoplanin's molecular mechanisms and biological functions continues to be a focus of active research worldwide. Investigating podoplanin expression patterns and interactions provides valuable insights into disease progression and potential therapeutic strategies. Research utilizing podoplanin monoclonal antibodies has revealed new pathways in cancer biology and vascular development. Ongoing studies of podoplanin contribute to advancing our knowledge of cellular processes and disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies for podoplanin research support scientists in making meaningful discoveries that advance our understanding of human health and disease.